Malenka on psychedelic drugs and disorders
Robert Malenka’s early research on the molecular mechanisms underlying memory and learning has led to an understanding of their role in psychiatric disorders including addiction, depression and autism spectrum disorder.
Mark Davis on immunology research
Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.
Ami Bhatt on gut microbiomes
The Stanford Medicine professor on why it’s important to better understand the microbiome of people transitioning from traditional to Westernized lifestyles.
Climate change and health
The director of the Center for Innovation in Global Health explains how the medical community is at the center of the climate change debate.
Tips for kids’ back-to-school anxiety
Returning to school as the pandemic stretches on may spark anxiety in young students, but there are approaches parents can use to build children’s resilience.
Wildfires and school ventilation
With the COVID-19 pandemic and the growth of wildfires, California schools need to improve their air quality, according to Stanford pediatrician Lisa Patel. Fortunately, the funds are available.
Schulman on value of new Alzheimer’s drug
The Food and Drug Administration has approved a new and expensive medication for Alzheimer’s disease, but it’s not clear it helps. Researcher Kevin Schulman discusses what the government should consider before deciding to cover it.
Animal-welfare awareness may lower meat consumption
Giving people information about animal welfare can motivate them to eat less meat, a meta-analysis of 100 studies has found.
Relman on investigating coronavirus’s origin
Microbiologist David Relman explores how the coronavirus could have emerged and why we need to know.
Stanford Health Care leads on patient surveys
Better questions, shorter surveys and faster data reporting will enable Stanford Health Care to rapidly improve the patient experience.